Construction of multifunctional stimuli-responsive nanosystems intelligently responsive to inner physiological and/or external irradiations based on nanobiotechnology can enable the on-demand drug release and improved diagnostic imaging to mitigate the side-effects of anticancer drugs and enhance the diagnostic/therapeutic outcome simultaneously. Here, a triple-functional stimuli-responsive nanosystem based on the co-integration of superparamagnetic Fe3O4 and paramagnetic MnOx nanoparticles (NPs) onto exfoliated graphene oxide (GO) nanosheets by a novel and efficient double redox strategy (DRS) is reported. Aromatic anticancer drug molecules can interact with GO nanosheets through supramolecular π stacking to achieve high drug loading capac...
Cancer, which is one of the top three causes of worldwide mortality, arises as a result of abnormal...
A nanotheranostics platform was synthesized based on PEGylated graphene oxide–gold nanoparticles and...
With the aim to obtain a site-specific doxorubicin (DOX) delivery in neuroblastoma SH-SY5Y cells, we...
Graphene Oxide (GO) has recently attracted substantial attention in biomedical field as an effective...
Success in disease therapy depends on precision medicines, where development of formulations with di...
Abstract Background In the last decade, graphene oxide-based nanomaterials, such as graphene oxide (...
Graphene and graphene-based nanomaterials such as graphene oxide (GO), reduced graphene oxide (rGO) ...
In this work, an efficient superparamagnetic iron oxide-reduced graphene oxide (Fe3O4-RGO) nanohybri...
Locating nanomedicines at the active sites plays a pivotal role in the nanoparticle-based cancer the...
Graphene oxide (GO) nanoparticles have been developed for a variety of biomedical applications as a ...
A novel graphene quantum dot (GQD)@Fe3O4@SiO2 based nanoprobe was reported for targeted drug deliver...
In this work, a nanoscale reduced graphene oxide-iron oxide nanoparticle (RGO-IONP) complex is nonco...
A pH-responsive nanocarrier is developed by coating nanoscale graphene oxide (NGO) with dual types o...
DoctorGraphene and graphene oxide (GO) has been widely investigated for biomedical applications due...
The integration of multiple therapeutic and diagnostic functions into a single nanoplatform for imag...
Cancer, which is one of the top three causes of worldwide mortality, arises as a result of abnormal...
A nanotheranostics platform was synthesized based on PEGylated graphene oxide–gold nanoparticles and...
With the aim to obtain a site-specific doxorubicin (DOX) delivery in neuroblastoma SH-SY5Y cells, we...
Graphene Oxide (GO) has recently attracted substantial attention in biomedical field as an effective...
Success in disease therapy depends on precision medicines, where development of formulations with di...
Abstract Background In the last decade, graphene oxide-based nanomaterials, such as graphene oxide (...
Graphene and graphene-based nanomaterials such as graphene oxide (GO), reduced graphene oxide (rGO) ...
In this work, an efficient superparamagnetic iron oxide-reduced graphene oxide (Fe3O4-RGO) nanohybri...
Locating nanomedicines at the active sites plays a pivotal role in the nanoparticle-based cancer the...
Graphene oxide (GO) nanoparticles have been developed for a variety of biomedical applications as a ...
A novel graphene quantum dot (GQD)@Fe3O4@SiO2 based nanoprobe was reported for targeted drug deliver...
In this work, a nanoscale reduced graphene oxide-iron oxide nanoparticle (RGO-IONP) complex is nonco...
A pH-responsive nanocarrier is developed by coating nanoscale graphene oxide (NGO) with dual types o...
DoctorGraphene and graphene oxide (GO) has been widely investigated for biomedical applications due...
The integration of multiple therapeutic and diagnostic functions into a single nanoplatform for imag...
Cancer, which is one of the top three causes of worldwide mortality, arises as a result of abnormal...
A nanotheranostics platform was synthesized based on PEGylated graphene oxide–gold nanoparticles and...
With the aim to obtain a site-specific doxorubicin (DOX) delivery in neuroblastoma SH-SY5Y cells, we...